A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes



      Mobile health (mHealth) platforms can affect health behaviors but have not been rigorously tested in randomized trials.


      We sought to evaluate the effectiveness of a pragmatic mHealth intervention in patients with heart failure (HF) and diabetes (DM).


      We conducted a multicenter randomized trial in 187 patients with both HF and DM to assess an mHealth intervention to improve physical activity and medication adherence compared to usual care. The primary endpoint was change in mean daily step count from baseline through 3 months. Other outcomes included medication adherence, health-related quality of life and metabolomic profiling.


      The mHealth group had an increase in daily step count of 151 steps/day at 3 months, whereas the usual-care group had a decline of 162 steps/day (least squares mean between-group difference = 313 steps/day; 95% CI: 8 619; P = 0.044). Medication adherence, measured using the Voils Adherence Questionnaire, did not change from baseline to 3 months (LS-mean change –0.08 in mHealth vs –0.15 in usual care; P = 0.47). The mHealth group had an improvement in Kansas City Cardiomyopathy Questionnaire Overall Summary Score compared to the usual-care group (LS-mean difference = 5.5 points, 95% CI: 1.4, 9.6; P = 0.009). Thirteen metabolites, primarily medium- and long-chain acylcarnitines, changed differently between treatment groups from baseline to 3 months (P < 0.05).


      In patients with HF and DM, a 3-month mHealth intervention significantly improved daily physical activity, health-related quality of life and metabolomic markers of cardiovascular health but not medication adherence.

      Condensed Abstract

      Heart failure (HF) and diabetes (DM) have overlapping biological and behavioral risk factors. We conducted a multicenter randomized, clinical trial in 187 patients with both HF (regardless of ejection fraction) and DM to assess whether an mHealth intervention could improve physical activity and medication adherence. The mHealth group had an increase in mean daily step count and quality of life but not in medication adherence. Medium- and long-chain acylcarnitines changed differently in treatment groups from baseline to 3 months (P < 0.05). These data have important implications for designing effective lifestyle interventions in HF and DM.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dunlay SM
        • Givertz MM
        • Aguilar D
        • Allen LA
        • Chan M
        • Desai AS
        • et al.
        Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.
        Circulation. 2019; 140: e294-e324
        • Kraus WE
        • Bittner V
        • Appel L
        • Blair SN
        • Church T
        • Després J-P
        • et al.
        The National Physical Activity Plan: A Call to Action From the American Heart Association: A Science Advisory From the American Heart Association.
        Circulation. 2015; 131: 1932-1940
        • Saint-Maurice PF
        • Troiano RP
        • Bassett Jr., DR
        • Graubard BI
        • Carlson SA
        • Shiroma EJ
        • et al.
        Association of Daily Step Count and Step Intensity With Mortality Among US Adults.
        Jama. 2020; 323: 1151-1160
        • Strain T
        • Wijndaele K
        • Dempsey PC
        • Sharp SJ
        • Pearce M
        • Jeon J
        • et al.
        Wearable-device-measured physical activity and future health risk.
        Nature Medicine. 2020; 26: 1385-1391
        • Lee IM
        • Shiroma EJ
        • Kamada M
        • Bassett DR
        • Matthews CE
        • Buring JE.
        Association of Step Volume and Intensity With All-Cause Mortality in Older Women.
        JAMA Internal Medicine. 2019; 179: 1105
        • O'Connor CM
        • Whellan DJ
        • Lee KL
        • Keteyian SJ
        • Cooper LS
        • Ellis SJ
        • et al.
        Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
        Jama. 2009; 301: 1439-1450
        • Flynn KE
        • Pina IL
        • Whellan DJ
        • Lin L
        • Blumenthal JA
        • Ellis SJ
        • et al.
        Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.
        Jama. 2009; 301: 1451-1459
        • Manjoo P
        • Joseph L
        • Dasgupta K.
        Abdominal adiposity and daily step counts as determinants of glycemic control in a cohort of patients with type 2 diabetes mellitus.
        Nutrition & Diabetes. 2012; 2: e25
        • Eapen ZJ
        • Peterson ED.
        Can mobile health applications facilitate meaningful behavior change?: Time for answers.
        JAMA. 2015; 314: 1236-1237
        • Burke LE
        • Ma J
        • Azar KMJ
        • Bennett GG
        • Peterson ED
        • Zheng Y
        • et al.
        Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention.
        Circulation. 2015; 132: 1157-1213
        • Sharma A
        • Mentz RJ
        • Granger BB
        • Heitner JF
        • Cooper LB
        • Banerjee D
        • et al.
        Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM Trial.
        Am Heart J. 2019; 211: 22-33
        • Granger BB
        • Locke SC
        • Bowers M
        • Sawyer T
        • Shang H
        • Abernethy AP
        • et al.
        The Digital Drag and Drop Pillbox: Design and Feasibility of a Skill-based Education Model to Improve Medication Management.
        J Cardiovasc Nurs. 2017; 32: E14-e20
        • Spratt SE
        • Ravneberg D
        • Derstine B
        • Granger BB.
        Feasibility of Electronic Health Record Integration of a SMART Application to Facilitate Patient-Provider Communication for Medication Management.
        Comput Inform Nurs. 2022; 40: 538-546
        • Shah SH
        • Bain JR
        • Muehlbauer MJ
        • Stevens RD
        • Crosslin DR
        • Haynes C
        • et al.
        Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events.
        Circulation Cardiovascular genetics. 2010; 3: 207-214
        • Shah SH
        • Sun JL
        • Stevens RD
        • Bain JR
        • Muehlbauer MJ
        • Pieper KS
        • et al.
        Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.
        Am Heart J. 2012; 163 (e1): 844-850
        • Shah SH
        • Hauser ER
        • Bain JR
        • Muehlbauer MJ
        • Haynes C
        • Stevens RD
        • et al.
        High heritability of metabolomic profiles in families burdened with premature cardiovascular disease.
        Mol Syst Biol. 2009; 5: 258
        • Bravata DM
        • Smith-Spangler C
        • Sundaram V
        • Gienger AL
        • Lin N
        • Lewis R
        • et al.
        Using pedometers to increase physical activity and improve health: a systematic review.
        Jama. 2007; 298: 2296-2304
        • Voils CI
        • Maciejewski ML
        • Hoyle RH
        • Reeve BB
        • Gallagher P
        • Bryson CL
        • et al.
        Initial validation of a self-report measure of the extent of and reasons for medication nonadherence.
        Med Care. 2012; 50: 1013-1019
        • Spertus J
        • Peterson E
        • Conard MW
        • Heidenreich PA
        • Krumholz HM
        • Jones P
        • et al.
        Monitoring clinical changes in patients with heart failure: a comparison of methods.
        Am Heart J. 2005; 150: 707-715
        • Shcherbina A
        • Hershman SG
        • Lazzeroni L
        • King AC
        • O'Sullivan JW
        • Hekler E
        • et al.
        The effect of digital physical activity interventions on daily step count: a randomised controlled crossover substudy of the MyHeart Counts Cardiovascular Health Study.
        Lancet Digit Health. 2019; 1: e344-e352
        • Lewis EF
        • Claggett BL
        • McMurray JJV
        • Packer M
        • Lefkowitz MP
        • Rouleau JL
        • et al.
        Health-Related Quality of Life Outcomes in PARADIGM-HF.
        Circ Heart Fail. 2017; 10
        • Kosiborod MN
        • Jhund PS
        • Docherty KF
        • Diez M
        • Petrie MC
        • Verma S
        • et al.
        Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
        Circulation. 2020; 141: 90-99
        • Althoff T
        • Sosic R
        • Hicks JL
        • King AC
        • Delp SL
        • Leskovec J.
        Large-scale physical activity data reveal worldwide activity inequality.
        Nature. 2017; 547: 336-339
        • Chow CK
        • Redfern J
        • Hillis GS
        • et al.
        Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: A randomized clinical trial.
        JAMA. 2015; 314: 1255-1263
        • Jakicic JM
        • Davis KK
        • Rogers RJ
        • King WC
        • Marcus MD
        • Helsel D
        • et al.
        Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss.
        JAMA. 2016; 316: 1161
        • Nolan RP
        • Ross HJ
        • Farkouh ME
        • Huszti E
        • Chan S
        • Toma M
        • et al.
        Automated E-Counseling for Chronic Heart Failure: CHF-CePPORT Trial.
        Circ Heart Fail. 2021; 14: 13-24
        • Hunter WG
        • Kelly JP
        • McGarrah 3rd, RW
        • Khouri MG
        • Craig D
        • Haynes C
        • et al.
        Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
        Journal of the American Heart Association. 2016; 5
        • Truby LK
        • Regan JA
        • Giamberardino SN
        • Ilkayeva O
        • Bain J
        • Newgard CB
        • et al.
        Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.
        Cardiovasc Diabetol. 2021; 20: 161